Bioengineers at Queen Mary University of London have taken a significant step forward in the development of laboratory-based ...

“You could see little parts of the human cell being broken off,” Ralston said of her very first encounter with the parasite.

A new class of molecules capable of killing the cancer cells that are refractory to standard treatments and responsible for recurrence has just been developed. This crucial advance in the fight ...

Influenza viruses are among the most likely triggers of future pandemics. A research team from the Helmholtz Center for Infection Research (HZI) and the Medical Center—University of Freiburg has ...

Current anticancer treatments essentially target the primary tumour cells that proliferate quickly, but do not effectively ...